Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $4,448 - $11,121
-22,242 Closed
0 $0
Q1 2022

Jun 30, 2022

SELL
$0.41 - $0.63 $657 - $1,009
-1,603 Reduced 6.72%
22,242 $12,000
Q4 2021

Feb 15, 2022

SELL
$0.57 - $1.29 $469 - $1,062
-824 Reduced 3.34%
23,845 $14,000
Q3 2021

Oct 29, 2021

SELL
$1.11 - $1.7 $1,107 - $1,696
-998 Reduced 3.89%
24,669 $30,000
Q2 2021

Aug 16, 2021

BUY
$1.46 - $2.25 $37,473 - $57,750
25,667 New
25,667 $43,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.